Antibiotic resistance and viral co-infection in children diagnosed with pneumonia caused by Mycoplasma pneumoniae admitted to Russian hospitals during October 2023—February 2024 | BMC Infectious Diseases

Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17(4):697–728, table of contents.

Waites KB, Xiao L, Liu Y, Balish MF, Atkinson TP. Mycoplasma pneumoniae from the Respiratory Tract and Beyond. Clin Microbiol Rev. 2017;30(3):747–809.

PubMed 
PubMed Central 

Google Scholar 

Zhao H, Li S, Cao L, Yuan Y, Xue G, Feng Y, et al. Surveillance of Mycoplasma pneumonia einfection among children in Beijing from 2007 to 2012. Chin Med J. 2014;127(7):1244.

PubMed 

Google Scholar 

Cheng Y, Cheng Y, Dai S, Hou D, Ge M, Zhang Y, et al. The Prevalence of Mycoplasma Pneumoniae Among Children in Beijing Before and During the COVID-19 Pandemic. Front Cell Infect Microbiol. 2022;12.

Onozuka D, Hashizume M, Hagihara A. Impact of weather factors on Mycoplasma pneumoniae pneumonia. Thorax. 2009;64(6):507–11.

PubMed 

Google Scholar 

Onozuka D, Chaves LF. Climate variability and nonstationary dynamics of Mycoplasma pneumoniae pneumonia in Japan. PLoS ONE. 2014;9(4): e95447.

PubMed 
PubMed Central 

Google Scholar 

Yamazaki T, Kenri T. Epidemiology of Mycoplasma pneumoniae Infections in Japan and Therapeutic Strategies for Macrolide-Resistant M. pneumoniae. Front Microbiol. 2016;7:693.

Meyer Sauteur PM, Beeton ML, Uldum SA, Bossuyt N, Vermeulen M, Loens K, et al. Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021. Euro Surveill. 2022;27(19):2100746.

PubMed 
PubMed Central 

Google Scholar 

Meyer Sauteur PM, Beeton ML, European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycoplasma and Chlamydia Infections (ESGMAC), and the ESGMAC Mycoplasma pneumoniae Surveillance (MAPS) study group. Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions. Lancet Microbe. 2024;5(2):e100–1.

Yan C, Xue GH, Zhao HQ, Feng YL, Cui JH, Yuan J. Current status of Mycoplasma pneumoniae infection in China. World Journal of Pediatrics. 2024;20(1):1.

PubMed 
PubMed Central 

Google Scholar 

Zhang XB, He W, Gui YH, Lu Q, Yin Y, Zhang JH, et al. Current Mycoplasma pneumoniae epidemic among children in Shanghai: unusual pneumonia caused by usual pathogen. World J Pediatr. 2024;20(1):5–10.

PubMed 

Google Scholar 

Schweon SJ. Global reemergence of Mycoplasma pneumoniae. Nursing2024. 2024;54(5):11.

Edouard S, Boughammoura H, Colson P, La Scola B, Fournier PE, Fenollar F. Large-Scale Outbreak of Mycoplasma pneumoniae Infection, Marseille, France, 2023–2024. Emerg Infect Dis. 2024;30(7):1481–4.

PubMed 
PubMed Central 

Google Scholar 

Bolluyt DC, Euser SM, Souverein D, van Rossum AM, Kalpoe J, van Westreenen M, et al. Increased incidence of Mycoplasma pneumoniae infections and hospital admissions in the Netherlands, November to December 2023. Euro Surveill. 2024;29(4):2300724.

PubMed 
PubMed Central 

Google Scholar 

Urbieta AD, Barbeito Castiñeiras G, Rivero Calle I, Pardo Seco J, Rodríguez Tenreiro C, Suárez Camacho R, et al. Mycoplasma pneumoniae at the rise not only in China: rapid increase of Mycoplasma pneumoniae cases also in Spain. Emerg Microbes Infect. 2024Dec;13(1):2332680.

PubMed 
PubMed Central 

Google Scholar 

Rachina SA, Kupryushina OA, Yasneva AS, Volosovtsova ES, Strelkova DA, Avdeev SN, Frangu RK, Merzhoeva ZM, Samokhina AS, Eryshova DS, Tikhonova MA, Yatsyshina SB. What Do We Know about Mycoplasmal Pneumonia? Pract Pulmonol. 2023;3:20–32.

Google Scholar 

Shin S, Koo S, Yang YJ, Lim HJ. Characteristics of the Mycoplasma pneumoniae Epidemic from 2019 to 2020 in Korea: Macrolide Resistance and Co-Infection Trends. Antibiotics (Basel). 2023;12(11):1623.

PubMed 

Google Scholar 

Zhou Y, Wang J, Chen W, Shen N, Tao Y, Zhao R, et al. Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia. BMC Infect Dis. 2020;20:633.

PubMed 
PubMed Central 

Google Scholar 

Li F, Zhang Y, Shi P, Cao L, Su L, Fu P, et al. Mycoplasma pneumoniae and Adenovirus Coinfection Cause Pediatric Severe Community-Acquired Pneumonia. Microbiol Spectr. 2022;10(2):e00026-e122.

PubMed 
PubMed Central 

Google Scholar 

Song Q, Xu BP, Shen KL. Effects of bacterial and viral co-infections of mycoplasma pneumoniae pneumonia in children: analysis report from Beijing Children’s Hospital between 2010 and 2014. Int J Clin Exp Med. 2015;8(9):15666–74.

PubMed 
PubMed Central 

Google Scholar 

Zhao M chuan, Wang L, Qiu F zhou, Zhao L, Guo W wei, Yang S, et al. Impact and clinical profiles of Mycoplasma pneumoniae co-detection in childhood community-acquired pneumonia. BMC Infect Dis. 2019;19:835.

Chiu CY, Chen CJ, Wong KS, Tsai MH, Chiu CH, Huang YC. Impact of bacterial and viral coinfection on mycoplasmal pneumonia in childhood community-acquired pneumonia. J Microbiol Immunol Infect. 2015;48(1):51–6.

PubMed 

Google Scholar 

Zhang X, Chen Z, Gu W, Ji W, Wang Y, Hao C, et al. Viral and bacterial co-infection in hospitalised children with refractory Mycoplasma pneumoniae pneumonia. Epidemiol Infect. 2018;146(11):1384–8.

PubMed 

Google Scholar 

Pereyre S, Goret J, Bébéar C. Mycoplasma pneumoniae: Current Knowledge on Macrolide Resistance and Treatment. Front Microbiol. 2016;7:974.

PubMed 
PubMed Central 

Google Scholar 

Tsai TA, Tsai CK, Kuo KC, Yu HR. Rational stepwise approach for Mycoplasma pneumoniae pneumonia in children. J Microbiol Immunol Infect. 2021;54(4):557–65.

PubMed 

Google Scholar 

Oishi T, Ouchi K. Recent Trends in the Epidemiology, Diagnosis, and Treatment of Macrolide-Resistant Mycoplasma pneumoniae. J Clin Med. 2022;11(7):1782.

PubMed 
PubMed Central 

Google Scholar 

Bébéar CM, Pereyre S. Mechanisms of drug resistance in Mycoplasma pneumoniae. Curr Drug Targets Infect Disord. 2005;5(3):263–71.

PubMed 

Google Scholar 

Bébéar C, Pereyre S, Peuchant O. Mycoplasma pneumoniae: susceptibility and resistance to antibiotics. Future Microbiol. 2011;6(4):423–31.

PubMed 

Google Scholar 

Principi N, Esposito S. Macrolide-resistant Mycoplasma pneumoniae: its role in respiratory infection. J Antimicrob Chemother. 2013;68(3):506–11.

PubMed 

Google Scholar 

Sulyok KM, Kreizinger Z, Wehmann E, Lysnyansky I, Bányai K, Marton S, et al. Mutations Associated with Decreased Susceptibility to Seven Antimicrobial Families in Field and Laboratory-Derived Mycoplasma bovis Strains. Antimicrob Agents Chemother. 2017;61(2):e01983-e2016.

PubMed 
PubMed Central 

Google Scholar 

Gautier-Bouchardon AV, Reinhardt AK, Kobisch M, Kempf I. In vitro development of resistance to enrofloxacin, erythromycin, tylosin, tiamulin and oxytetracycline in Mycoplasma gallisepticum, Mycoplasma iowae and Mycoplasma synoviae. Vet Microbiol. 2002;88(1):47–58.

PubMed 

Google Scholar 

Gruson D, Pereyre S, Renaudin H, Charron A, Bébéar C, Bébéar CM. In vitro development of resistance to six and four fluoroquinolones in Mycoplasma pneumoniae and Mycoplasma hominis, respectively. Antimicrob Agents Chemother. 2005;49(3):1190–3.

PubMed 
PubMed Central 

Google Scholar 

Yoshida H, Bogaki M, Nakamura M, Nakamura S. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob Agents Chemother. 1990;34(6):1271–2.

PubMed 
PubMed Central 

Google Scholar 

Bébéar CM, Renaudin H, Charron A, Clerc M, Pereyre S, Bébéar C. DNA gyrase and topoisomerase IV mutations in clinical isolates of Ureaplasma spp. and Mycoplasma hominis resistant to fluoroquinolones. Antimicrob Agents Chemother. 2003;47(10):3323–5.

Kenri T, Yamazaki T, Ohya H, Jinnai M, Oda Y, Asai S, et al. Genotyping of Mycoplasma pneumoniae strains isolated in Japan during 2019 and 2020: spread of p1 gene type 2c and 2j variant strains. Front Microbiol. 2023;14.

Edelstein I, Rachina S, Touati A, Kozlov R, Henin N, Bébéar C, et al. Mycoplasma pneumoniae Monoclonal P1 Type 2c Outbreak, Russia, 2013. Emerg Infect Dis. 2016;22(2):348–50.

PubMed 
PubMed Central 

Google Scholar 

Liu Y, Ye X, Zhang H, Xu X, Li W, Zhu D, et al. Antimicrobial Susceptibility of Mycoplasma pneumoniae Isolates and Molecular Analysis of Macrolide-Resistant Strains from Shanghai. China Antimicrobial Agents and Chemotherapy. 2009;53(5):2160–2.

PubMed 

Google Scholar 

Chanock RM, Hayflick L, Barile MF. Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a pplo. Proc Natl Acad Sci. 1962;48(1):41–9.

PubMed 
PubMed Central 

Google Scholar 

Hayflick L, Chanock RM. Mycoplasma Species of Man. Bacteriol Rev. 1965;29(2):185–221.

PubMed 
PubMed Central 

Google Scholar 

Wick RR, Judd LM, Holt KE. Performance of neural network basecalling tools for Oxford Nanopore sequencing. Genome Biol. 2019;20(1):129.

PubMed 
PubMed Central 

Google Scholar 

Li H. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics. 2018;34(18):3094–100.

PubMed 
PubMed Central 

Google Scholar 

Danecek P, Bonfield JK, Liddle J, Marshall J, Ohan V, Pollard MO, et al. Twelve years of SAMtools and BCFtools. Gigascience. 2021;10(2):giab008.

Medaka 2018- Oxford Nanopore Technologies Ltd, available online, (accessed 1 March 2024).

Gurevich A, Saveliev V, Vyahhi N, Tesler G. QUAST: quality assessment tool for genome assemblies. Bioinformatics. 2013;29(8):1072–5.

PubMed 
PubMed Central 

Google Scholar 

Li W, O’Neill KR, Haft DH, DiCuccio M, Chetvernin V, Badretdin A, et al. RefSeq: expanding the Prokaryotic Genome Annotation Pipeline reach with protein family model curation. Nucleic Acids Res. 2021;49(D1):D1020–8.

PubMed 

Google Scholar 

Kurtz S, Phillippy A, Delcher AL, Smoot M, Shumway M, Antonescu C, et al. Versatile and open software for comparing large genomes. Genome Biol. 2004;5(2):R12.

PubMed 
PubMed Central 

Google Scholar 

Feldgarden M, Brover V, Gonzalez-Escalona N, Frye JG, Haendiges J, Haft DH, et al. AMRFinderPlus and the Reference Gene Catalog facilitate examination of the genomic links among antimicrobial resistance, stress response, and virulence. Sci Rep. 2021;11(1):12728.

PubMed 
PubMed Central 

Google Scholar 

Bonin N, Doster E, Worley H, Pinnell LJ, Bravo JE, Ferm P, et al. MEGARes and AMR++, v3.0: an updated comprehensive database of antimicrobial resistance determinants and an improved software pipeline for classification using high-throughput sequencing. Nucleic Acids Res. 2023;51(D1):D744–52.

Camargo AP, Roux S, Schulz F, Babinski M, Xu Y, Hu B, et al. Identification of mobile genetic elements with geNomad. Nat Biotechnol. 2024;42(8):1303–12.

PubMed 

Google Scholar 

NIH Comparative Genomics Resource (CGR) – NCBI – NLM.

Page AJ, Cummins CA, Hunt M, Wong VK, Reuter S, Holden MTG, et al. Roary: rapid large-scale prokaryote pan genome analysis. Bioinformatics. 2015;31(22):3691–3.

PubMed 
PubMed Central 

Google Scholar 

Nguyen LT, Schmidt HA, von Haeseler A, Minh BQ. IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol Biol Evol. 2015;32(1):268–74.

PubMed 

Google Scholar 

Kalyaanamoorthy S, Minh BQ, Wong TKF, von Haeseler A, Jermiin LS. ModelFinder: fast model selection for accurate phylogenetic estimates. Nat Methods. 2017;14(6):587–9.

PubMed 
PubMed Central 

Google Scholar 

Sayers E. A General Introduction to the E-utilities. In: Entrez Programming Utilities Help. National Center for Biotechnology Information (US); 2022.

Letunic I, Bork P. Interactive Tree of Life (iTOL) v6: recent updates to the phylogenetic tree display and annotation tool. Nucleic Acids Res. 2024;gkae268.

Xu M, Li Y, Shi Y, Liu H, Tong X, Ma L, et al. Molecular epidemiology of Mycoplasma pneumoniae pneumonia in children, Wuhan, 2020–2022. BMC Microbiol. 2024;24:23.

PubMed 
PubMed Central 

Google Scholar 

Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics. 2014;30(14):2068–9.

PubMed 

Google Scholar 

Hsieh YC, Li SW, Chen YY, Kuo CC, Chen YC, Chang IYF, et al. Global Genome Diversity and Recombination in Mycoplasma pneumoniae. Emerg Infect Dis. 2022;28(1):111–7.

PubMed 
PubMed Central 

Google Scholar 

Voronina EN, Gordukova MA, Turina IE, Mishukova OV, Dymova MA, Galeeva EV, et al. Molecular characterization of Mycoplasma pneumoniae infections in Moscow from 2015 to 2018. Eur J Clin Microbiol Infect Dis. 2020;39(2):257–63.

PubMed 

Google Scholar 

Jacobs E, Ehrhardt I, Dumke R. New insights in the outbreak pattern of Mycoplasma pneumoniae. Int J Med Microbiol. 2015;305(7):705–8.

PubMed 

Google Scholar 

Uldum SA, Bangsborg JM, Gahrn-Hansen B, Ljung R, Mølvadgaard M, Føns Petersen R, et al. Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011. Euro Surveill. 2012;17(5):20073.

PubMed 

Google Scholar 

Beeton ML, Zhang XS, Uldum SA, Bébéar C, Dumke R, Gullsby K, et al. Mycoplasma pneumoniae infections, 11 countries in Europe and Israel, 2011 to 2016. Euro Surveill. 2020;25(2):1900112.

PubMed 
PubMed Central 

Google Scholar 

Meyer Sauteur PM, Krautter S, Ambroggio L, Seiler M, Paioni P, Relly C, et al. Improved Diagnostics Help to Identify Clinical Features and Biomarkers That Predict Mycoplasma pneumoniae Community-acquired Pneumonia in Children. Clin Infect Dis. 2020;71(7):1645–54.

PubMed 

Google Scholar 

Choo S, Lee YY, Lee E. Clinical significance of respiratory virus coinfection in children with Mycoplasma pneumoniae pneumonia. BMC Pulm Med. 2022;22:212.

PubMed 
PubMed Central 

Google Scholar 

Michelow IC, Olsen K, Lozano J, Rollins NK, Duffy LB, Ziegler T, et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics. 2004;113(4):701–7.

PubMed 

Google Scholar 

Toikka P, Juvén T, Virkki R, Leinonen M, Mertsola J, Ruuskanen O. Streptococcus pneumoniae and Mycoplasma pneumoniae coinfection in community acquired pneumonia. Arch Dis Child. 2000;83(5):413–4.

PubMed 
PubMed Central 

Google Scholar 

Heiskanen-Kosma T, Korppi M, Jokinen C, Kurki S, Heiskanen L, Juvonen H, et al. Etiology of childhood pneumonia: serologic results of a prospective, population-based study. Pediatr Infect Dis J. 1998;17(11):986–91.

PubMed 

Google Scholar 

Korppi M. Mixed microbial aetiology of community-acquired pneumonia in children. APMIS. 2002;110(7–8):515–22.

PubMed 

Google Scholar 

Guo Q, Li L, Wang C, Huang Y, Ma F, Cong S, et al. Comprehensive virome analysis of the viral spectrum in paediatric patients diagnosed with Mycoplasma pneumoniae pneumonia. Virol J. 2022;19(1):181.

PubMed 
PubMed Central 

Google Scholar 

Søndergaard MJ, Friis MB, Hansen DS, Jørgensen IM. Clinical manifestations in infants and children with Mycoplasma pneumoniae infection. PLoS ONE. 2018;13(4): e0195288.

PubMed 
PubMed Central 

Google Scholar 

Zhao J, Xu M, Tian Z, Wang Y. Clinical characteristics of pathogens in children with community-acquired pneumonia were analyzed via targeted next-generation sequencing detection. PeerJ. 2025;13: e18810.

PubMed 
PubMed Central 

Google Scholar 

Li N, Qiang G feng, Liu R han, Meng L lan, Ning J, Shen C qing, et al. Analysis of clinical characteristics of severe mycoplasma pneumoniae pneumonia complicated with virus infection in children. Research Square; 2024.

Chi J, Tang H, Wang F, Wang Y, Chen Z. Surge in Mycoplasma Pneumoniae infection and Respiratory Viruses Co-infection in Children With Community-Acquired Pneumonia in the Post-Pandemic. Pediatric Health Med Ther. 2024;15:279–88.

PubMed 
PubMed Central 

Google Scholar 

Wang N, Xu X, Xiao L, Liu Y. Novel mechanisms of macrolide resistance revealed by in vitro selection and genome analysis in Mycoplasma pneumoniae. Front Cell Infect Microbiol. 2023May;22(13):1186017.

Google Scholar 

Kim K, Jung S, Kim M, Park S, Yang HJ, Lee E. Global Trends in the Proportion of Macrolide-Resistant Mycoplasma pneumoniae Infections: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022;5(7): e2220949.

PubMed 
PubMed Central 

Google Scholar 

Loconsole D, De Robertis AL, Sallustio A, Centrone F, Morcavallo C, Campanella S, et al. Update on the Epidemiology of Macrolide-Resistant Mycoplasma pneumoniae in Europe: A Systematic Review. Infect Dis Rep. 2021;13(3):811–20.

PubMed 
PubMed Central 

Google Scholar 

Ferguson GD, Gadsby NJ, Henderson SS, Hardie A, Kalima P, Morris AC, et al. Clinical outcomes and macrolide resistance in Mycoplasma pneumoniae infection in Scotland. UK J Med Microbiol. 2013;62(Pt 12):1876–82.

PubMed 

Google Scholar 

Waites KB, Ratliff A, Crabb DM, Xiao L, Qin X, Selvarangan R, et al. Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program. J Clin Microbiol. 2019;57(11):e00968-e1019.

PubMed 
PubMed Central 

Google Scholar 

Guo D, Hu W, Xu B, Li J, Li D, Li S, et al. Allele-specific real-time PCR testing for minor macrolide-resistant Mycoplasma Pneumoniae. BMC Infect Dis. 2019;19:616.

PubMed 
PubMed Central 

Google Scholar 

Qu J, Chen S, Bao F, Gu L, Cao B. Molecular characterization and analysis of Mycoplasma pneumoniae among patients of all ages with community-acquired pneumonia during an epidemic in China. Int J Infect Dis. 2019;83:26–31.

PubMed 

Google Scholar 

Wang N, Zhang H, Yin Y, Xu X, Xiao L, Liu Y. Antimicrobial Susceptibility Profiles and Genetic Characteristics of Mycoplasma pneumoniae in Shanghai, China, from 2017 to 2019. Infect Drug Resist. 2022;15:4443–52.

PubMed 
PubMed Central 

Google Scholar 

Wang G, Wu P, Tang R, Zhang W. Global prevalence of resistance to macrolides in Mycoplasma pneumoniae: a systematic review and meta-analysis. J Antimicrob Chemother. 2022;77(9):2353–63.

PubMed 

Google Scholar 

Lee JK, Choi YY, Sohn YJ, Kim KM, Kim YK, Han MS, et al. Persistent high macrolide resistance rate and increase of macrolide-resistant ST14 strains among Mycoplasma pneumoniae in South Korea, 2019–2020. J Microbiol Immunol Infect. 2022;55(5):910–6.

PubMed 

Google Scholar 

Tanaka T, Oishi T, Miyata I, Wakabayashi S, Kono M, Ono S, et al. Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008–2015. Emerg Infect Dis. 2017;23(10):1703–6.

PubMed 
PubMed Central 

Google Scholar 

Spuesens EBM, Fraaij PLA, Visser EG, Hoogenboezem T, Hop WCJ, van Adrichem LNA, et al. Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study. PLoS Med. 2013;10(5): e1001444.

PubMed 
PubMed Central 

Google Scholar 

Meyer Sauteur PM, Unger WWJ, Nadal D, Berger C, Vink C, van Rossum AMC. Infection with and Carriage of Mycoplasma pneumoniae in Children. Front Microbiol. 2016;7:329.

PubMed 
PubMed Central 

Google Scholar 

Daxboeck F, Krause R, Wenisch C. Laboratory diagnosis of Mycoplasma pneumoniae infection. Clin Microbiol Infect. 2003;9(4):263–73.

PubMed 

Google Scholar